23983-05-3 Usage
Uses
Used in Pharmaceutical Industry:
(2Z)-2-(2-chlorobenzylidene)[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one is used as a potential antifungal and antibacterial agent due to its demonstrated biological activities. Its unique structure and properties make it a promising candidate for the development of new drugs to combat resistant strains of fungi and bacteria.
Used in Medicinal Chemistry Research:
(2Z)-2-(2-chlorobenzylidene)[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one is used as a subject of research in medicinal chemistry to explore its pharmacological potential and understand its mechanism of action. Further studies are needed to fully comprehend its applications in various fields and to develop new therapeutic agents based on its structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 23983-05-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,8 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23983-05:
(7*2)+(6*3)+(5*9)+(4*8)+(3*3)+(2*0)+(1*5)=123
123 % 10 = 3
So 23983-05-3 is a valid CAS Registry Number.
23983-05-3Relevant academic research and scientific papers
Fused Thiazoles: Synthesis and Antifungal Activity of 2-Arylidenethiazoloimidazopyridin-3(2H)-ones, 2-Arylidenethiazolobenzimidazol-3(2H)-ones and 6-Arylidenethiazolo-s-triazol-5(6H)-ones
Prasad, A. R.,Rao, A. Narasimha,Ramalingam, T.,Sattur, P. B.
, p. 776 - 778 (2007/10/02)
One-pot synthesis of the title compounds (II, IV) starting from 2-mercapto-1H-imidazopyridines (I; X=N), 2-mercaptobenzimidazoles (I; X=CH) or 5-aryl-3-mercapto-1,2,4-triazoles (III) is described.These compounds have been screened for their antifungal activities.
Synthesis of New 2-Substituted Benzylidenethiazolobenzimidazol-3(2H)-ones and Their Biological Activity
Soni, Namita,Barthwal, J. P.,Gupta, T. K.,Bhalla, T. N.,Parmar, S. S.,Bhargava, K. P.
, p. 785 - 788 (2007/10/02)
2-Substituted benzylidenethiazolobenzimidazol-3(2H)-ones (I-XIV) have been synthesized and found to possess anticonvulsant activity (0-60percent).These compounds also inhibit rat brain monoamine oxidase (MAO) (33.70-98.30percent) and succinate dehydrogenase (SDH) (25.72-78.95percent) in vitro of concentrations 4E-4 M and 6E-4 M, respectively.Structure-activity relationship has been dicussed.
